A detailed history of Putnam Investments LLC transactions in Incyte Corp stock. As of the latest transaction made, Putnam Investments LLC holds 198,578 shares of INCY stock, worth $16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
198,578
Previous 189,029 5.05%
Holding current value
$16 Million
Previous $10.9 Million 14.18%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $498,075 - $612,950
9,549 Added 5.05%
198,578 $12.5 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $7.8 Million - $8.9 Million
134,959 Added 249.6%
189,029 $10.9 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $4.07 Million - $5.05 Million
-66,822 Reduced 55.27%
54,070 $3.37 Million
Q1 2023

May 22, 2023

BUY
$70.23 - $86.01 $5.65 Million - $6.92 Million
80,469 Added 199.07%
120,892 $8.74 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $309,162 - $387,074
-4,602 Reduced 10.22%
40,423 $3.25 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $127,330 - $159,422
-1,924 Reduced 4.1%
45,025 $3 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $763,584 - $959,730
-11,538 Reduced 19.73%
46,949 $3.57 Million
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $14.1 Million - $17.1 Million
-214,103 Reduced 78.54%
58,487 $4.65 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $9.47 Million - $11.1 Million
149,515 Added 121.48%
272,590 $20 Million
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $482,338 - $590,156
-7,024 Reduced 5.4%
123,075 $8.47 Million
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $10.4 Million - $11.4 Million
130,099 New
130,099 $10.9 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $258,125 - $312,346
-3,197 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$85.07 - $109.69 $10,123 - $13,053
-119 Reduced 3.59%
3,197 $287,000
Q2 2020

Aug 14, 2020

BUY
$74.18 - $108.93 $245,980 - $361,211
3,316 New
3,316 $345,000
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $3.35 Million - $4.63 Million
-55,121 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$83.06 - $100.98 $4.37 Million - $5.31 Million
52,629 Added 2111.92%
55,121 $4.59 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $46,780 - $58,300
-500 Reduced 16.71%
2,492 $236,000
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $326,576 - $413,703
2,992
2,992 $349,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.